Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Immunology|November 1, 1980
Study of the effect of single or multiple doses of BCG on antibody-dependent cellular cytotoxicityN Kiger, M Bruley-Rosset, R Huchet, et al.Clinical and Experimental Immunology|March 26, 2003
Differences in MHC-class I presented minor histocompatibility antigens extracted from normal and graft-versus-host disease (GVHD) miceM Bruley Rosset, V Tieng, D Charron, et al.European Journal of Immunology|December 1, 1987
Abrogation of the lethal graft-vs.-host reaction developed to non-H-2 antigens: involvement of T suppressor cells distinct from veto cellsO Halle-Pannenko, L L Pritchard, M Bruley-RossetTransplantation|September 27, 1996
Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299J Annat, E Churaqui, P Dutartre, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 15, 1990
Mlsa generated suppressor cells. I. Suppression is mediated by double-negative (CD3+CD5+CD4-CD8-) alpha/beta T cell receptor-bearing cellsM Bruley-Rosset, I Miconnet, C Canon, et al.International Archives of Allergy and Applied Immunology|January 1, 1976
Nonspecific macrophage activation by systemic adjuvants. Evaluation by lysosomal enzyme and in vitro tumoricidal activitiesM Bruley-Rosset, I Florentin, A M Khalil, et al.Bone Marrow Transplantation|May 25, 1999
CD8+ cytotoxic T cell repertoire implicated in grafts-versus-leukemia effect in a murine bone marrow transplantation modelV de La Selle, N Riché, G Dorothé, et al.Bone Marrow Transplantation|July 1, 1995
Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effectV de la Selle, I Miconnet, D Gilbert, et al.Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|December 1, 1977
Heat-killed Pseudomonas aeruginosa as a systemic adjuvant in cancer immunotherapyG Mathé, I Florentin, M Bruley-Rosset, et al.Transplantation|April 1, 1989
Lethal graft-versus-host reaction against non-H-2 antigens. I. Prevention of GVH-associated immunodeficiency by preimmunizing the donor against host-specific non-H-2 antigensM Bruley-Rosset, L L Pritchard, M Zohar, et al.Pageof 5